These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31268707)

  • 1. Opportunities and Challenges in Phenotypic Screening for Neurodegenerative Disease Research.
    Brown DG; Wobst HJ
    J Med Chem; 2020 Mar; 63(5):1823-1840. PubMed ID: 31268707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
    Taylor J; Woodcock S
    J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas9 knockout screening for functional genomics.
    Shen Z; Ou G
    Sci China Life Sci; 2014 Jul; 57(7):733-4. PubMed ID: 25005538
    [No Abstract]   [Full Text] [Related]  

  • 4. Functional Genomics and High Content Screening in the Nervous System.
    Lerch JK; Buchser W
    Mol Cell Neurosci; 2017 Apr; 80():159-160. PubMed ID: 28413055
    [No Abstract]   [Full Text] [Related]  

  • 5. High content screening in neurodegenerative diseases.
    Jain S; van Kesteren RE; Heutink P
    J Vis Exp; 2012 Jan; (59):e3452. PubMed ID: 22257990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas9 System: Opportunities and Concerns.
    Vasiliou SK; Diamandis EP; Church GM; Greely HT; Baylis F; Thompson C; Schmitt-Ulms G
    Clin Chem; 2016 Oct; 62(10):1304-11. PubMed ID: 27551006
    [No Abstract]   [Full Text] [Related]  

  • 7. Active Learning Strategies for Phenotypic Profiling of High-Content Screens.
    Smith K; Horvath P
    J Biomol Screen; 2014 Jun; 19(5):685-95. PubMed ID: 24643256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in technologies for 3D genomics research.
    Zhang Y; Li G
    Sci China Life Sci; 2020 Jun; 63(6):811-824. PubMed ID: 32394244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential application and challenge of powerful CRISPR/Cas9 system in cardiovascular research.
    Li Y; Song YH; Liu B; Yu XY
    Int J Cardiol; 2017 Jan; 227():191-193. PubMed ID: 27847153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Based Lentiviral Knockout Libraries for Functional Genomic Screening and Identification of Phenotype-Related Genes.
    Thomsen EA; Mikkelsen JG
    Methods Mol Biol; 2019; 1961():343-357. PubMed ID: 30912056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidating drug targets and mechanisms of action by genetic screens in mammalian cells.
    Kampmann M
    Chem Commun (Camb); 2017 Jun; 53(53):7162-7167. PubMed ID: 28487920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CRISPR toolbox to study virus-host interactions.
    Puschnik AS; Majzoub K; Ooi YS; Carette JE
    Nat Rev Microbiol; 2017 Jun; 15(6):351-364. PubMed ID: 28420884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Power of Zebrafish in Personalised Medicine.
    Baxendale S; van Eeden F; Wilkinson R
    Adv Exp Med Biol; 2017; 1007():179-197. PubMed ID: 28840558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comprehensive Protocol Resource for Performing Pooled shRNA and CRISPR Screens.
    Cluse LA; Nikolic I; Knight D; Madhamshettiwar PB; Luu J; Cowley KJ; Semple T; Arnau GM; Shortt J; Johnstone RW; Simpson KJ
    Methods Mol Biol; 2018; 1725():201-227. PubMed ID: 29322420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic screens targeting neurodegenerative diseases.
    Zhang M; Luo G; Zhou Y; Wang S; Zhong Z
    J Biomol Screen; 2014 Jan; 19(1):1-16. PubMed ID: 23958650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What have we learned recently from transgenic mouse models about neurodegeneration? The most promising discoveries of this millennium.
    Kreiner G
    Pharmacol Rep; 2018 Dec; 70(6):1105-1115. PubMed ID: 30312896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Think big - think omics.
    Wevers RA; Blau N
    J Inherit Metab Dis; 2018 May; 41(3):281-283. PubMed ID: 29541953
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens.
    Haney MS; Bohlen CJ; Morgens DW; Ousey JA; Barkal AA; Tsui CK; Ego BK; Levin R; Kamber RA; Collins H; Tucker A; Li A; Vorselen D; Labitigan L; Crane E; Boyle E; Jiang L; Chan J; Rincón E; Greenleaf WJ; Li B; Snyder MP; Weissman IL; Theriot JA; Collins SR; Barres BA; Bassik MC
    Nat Genet; 2018 Dec; 50(12):1716-1727. PubMed ID: 30397336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR Editing Technology in Biological and Biomedical Investigation.
    White MK; Kaminski R; Young WB; Roehm PC; Khalili K
    J Cell Biochem; 2017 Nov; 118(11):3586-3594. PubMed ID: 28460414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-mediated gene editing for the surgeon scientist.
    O'Brien SJ; Ekman MB; Manek S; Galandiuk S
    Surgery; 2019 Aug; 166(2):129-137. PubMed ID: 30922545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.